BANK OF MONTREAL /CAN/ - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$373,546
-24.4%
7,992
-6.4%
0.00%
Q2 2023$494,319
+132.5%
8,536
+15.1%
0.00%
Q4 2022$212,634
-4.2%
7,414
+8.8%
0.00%
Q3 2022$222,000
-0.4%
6,816
+4.9%
0.00%
Q2 2022$223,000
-53.2%
6,495
-50.1%
0.00%
Q1 2022$477,000
+60.1%
13,029
+2.9%
0.00%
Q4 2021$298,000
+6.8%
12,658
-11.6%
0.00%
Q3 2021$279,000
-15.7%
14,317
-9.8%
0.00%
Q2 2021$331,000
+61.5%
15,868
+37.2%
0.00%
Q1 2021$205,000
-5.5%
11,569
+3.9%
0.00%
Q4 2020$217,000
-91.9%
11,132
-91.6%
0.00%
-100.0%
Q3 2020$2,680,000
-6.1%
132,595
-3.2%
0.00%
-33.3%
Q2 2020$2,853,000
+65.5%
137,002
+17.4%
0.00%
+50.0%
Q1 2020$1,724,000
-26.8%
116,732
-4.4%
0.00%0.0%
Q4 2019$2,355,000
+105.9%
122,074
+111.6%
0.00%
+100.0%
Q3 2019$1,144,000
+1000.0%
57,700
+1072.0%
0.00%
Q2 2019$104,000
+141.9%
4,923
+130.7%
0.00%
Q1 2019$43,000
-12.2%
2,134
-12.7%
0.00%
Q4 2018$49,000
+16.7%
2,445
+12.0%
0.00%
Q3 2018$42,000
+27.3%
2,184
-0.3%
0.00%
Q2 2018$33,000
-5.7%
2,191
+17.4%
0.00%
Q1 2018$35,000
-62.4%
1,867
-61.6%
0.00%
Q4 2017$93,000
-92.5%
4,867
-93.0%
0.00%
-100.0%
Q3 2017$1,245,000
+0.1%
69,6490.0%0.00%0.0%
Q2 2017$1,244,000
+1297.8%
69,649
+1032.9%
0.00%
Q1 2017$89,000
-97.6%
6,148
-96.6%
0.00%
-100.0%
Q4 2016$3,696,000
+134.4%
182,305
+119.3%
0.00%
+100.0%
Q3 2016$1,577,000
+440.1%
83,120
+358.7%
0.00%
Q2 2016$292,000
+311.3%
18,120
+204.2%
0.00%
Q1 2016$71,000
+6.0%
5,956
+26.7%
0.00%
Q4 2015$67,000
-73.0%
4,700
-77.8%
0.00%
Q3 2015$248,000
-18.4%
21,172
+22.4%
0.00%
Q2 2015$304,000
+86.5%
17,292
+58.8%
0.00%
Q1 2015$163,000
+608.7%
10,886
+444.3%
0.00%
Q4 2014$23,0000.0%2,0000.0%0.00%
Q3 2014$23,0002,0000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders